Clinical Aspects and Risk Factors of Nosocomial Stenotrophomonas maltophilia Bacteremia Episodes in a Turkish Intensive Care Unit

References

• Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11: 57–80.
   PubMed Web of Science ®Google Scholar
• Marshall WF, Keating MR, Anhalt JP, Steckelberg JM. Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc 1989; 64: 1097–1104.
   PubMed Web of Science ®Google Scholar
• Muder RR, Yu VL, Dummer JS, Vinson C, Lumish RM. Infections caused by Pseudomonas maltophilia: expanding clinical spectrum. Arch Intern Med 1987; 147: 1672–1674.
   PubMed Web of Science ®Google Scholar
• Rello J, Ricart M, Mirelis B, et al. Nosocomial bac-teremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 1994; 20: 94–98.
   PubMed Web of Science ®Google Scholar
• Krcmery V, Pichna P, Oravcoca E, et al. Stenotrophomonas maltophilia bacteremia in cancer patients: report on 31 cases. J Hosp Infect 1996; 34: 75–77.
   PubMed Web of Science ®Google Scholar
• Elting LS, Khardori N, Bodey GP, Fainstein V. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11: 134–138.
   PubMed Web of Science ®Google Scholar
• Alonso A, Martinez JL. Multipl antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1997; 41: 1140–1142.
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–140.
   PubMed Web of Science ®Google Scholar
• Sherertz RJ. Surveillance for infections associated with vascular catheters: Infect Control Hosp Epidemiol 1996; 17: 746–752.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease clacification system. Crit Care Med 1985; 13: 818–29.
   PubMed Web of Science ®Google Scholar
• Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hema-tologic malignancies. Clin Infect Dis 2000; 31: 705–711.
   PubMed Web of Science ®Google Scholar
• Muder RR, Hans AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospective, multicenter study of 91 episodes. Clin Infcet Dis 1996; 22: 508–512.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: Sixteenth informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA, USA; 2006.
   Google Scholar
• Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine 1990; 69: 296–306.
   PubMed Web of Science ®Google Scholar
• Khardori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 1990; 12: 997–1003.
   PubMedGoogle Scholar
• Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epi-demiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001; 32 (Suppl 2): S104–113.
   PubMed Web of Science ®Google Scholar
• Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 2002; 34: 1653–1656.
   PubMed Web of Science ®Google Scholar
• Lai CH, Chi CY, Chen HP, et al. Clinical characteris-tics and prognostic factors of patients with Stenotropho-monas maltophilia bacteremia. J Microbiol Immunol Infect 2004; 37: 350–358.
   PubMedGoogle Scholar
• Hanes SD, Demirkan K, Tolley E, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotro-phomonas maltophilia in critically ill trauma patients. Clin Infect Dis 2002; 35: 228–235.
   PubMed Web of Science ®Google Scholar
• Schaumann R, Stein K, Eckhardt C, Ackermann G, Rodloff AC. Infections caused by Stenotrophomonas mal-tophilia--a prospective study. Infection 2001; 29: 205–208.
   PubMed Web of Science ®Google Scholar
• Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW. Bacteremia due to Stenotrophomonas mal-tophilia: An analysis of 45 episodes. J Infection 2002; 45: 47–53.
   PubMed Web of Science ®Google Scholar
• Khardori N, Reuben A, Rosenbaum B, Rolston K, Bodey GP. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob Agents Chemother 1990; 34: 1609–1610.
   PubMed Web of Science ®Google Scholar
• Wang WS, Liu CP, Lee CM, Huang FY. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 2004; 37: 359–365.
   PubMedGoogle Scholar
• Krueger TS, Clark EA, Nix DE. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial com-binations. Diagn Microbial Infect Dis 2001; 41: 71–78.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li XZ, Poole K. Multiple antibiotic resistance in Stenotrophomonas maltophilia: Involvement of a mul-tidrug efflux system. Antimicrob Agents Chemother 2000; 44: 287–293.
   PubMed Web of Science ®Google Scholar
• Bellido JL, Hernandez FJ, Zufiaurre MN, Garcia-Rodrigez JA: In vitro activity of newer fluoroquinolones against Stenotrophomonas maltophilia: J Antimicrob Chemother 2000; 46: 334-335.
   PubMed Web of Science ®Google Scholar
• Sattler CA, Mason EO, Kaplan SL. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hos-pital. Clin Infect Dis 2000; 31: 1321–1330.
   PubMed Web of Science ®Google Scholar